APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antithyroid Drug Market Analysis and Forecast 2026-2032

Report ID 17396667022 January 2026190 pages

Choose your research edition.

Industry ResearchAntithyroid Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Antithyroid Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antithyroid Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antithyroid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antithyroid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antithyroid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antithyroid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antithyroid Drug include Avet Pharmaceuticals Inc., Par Pharmaceutical, Zhaohui Pharmaceutical, Hemony Pharmaceutical, Pfizer Inc, Merck KGaA, Teva Pharmaceuticals and YanJing Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antithyroid Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antithyroid Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Antithyroid Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antithyroid Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antithyroid Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antithyroid Drug sales, projected growth trends, production technology, application and end-user industry.

Antithyroid Drug Segment by Company

Avet Pharmaceuticals Inc.

Par Pharmaceutical

Zhaohui Pharmaceutical

Hemony Pharmaceutical

Pfizer Inc

Merck KGaA

Teva Pharmaceuticals

YanJing Pharm

Antithyroid Drug Segment by Type

Methimazole

Propylthiouracil

Other

Antithyroid Drug Segment by Application

Hospital

Pharmacy

Other

Antithyroid Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antithyroid Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antithyroid Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antithyroid Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antithyroid Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Methimazole Major Manufacturers Table 3. Propylthiouracil Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Antithyroid Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Other Major Manufacturers Table 9. Antithyroid Drug Industry Trends Table 10. Antithyroid Drug Industry Drivers Table 11. Antithyroid Drug Industry Opportunities and Challenges Table 12. Antithyroid Drug Industry Restraints Table 13. Global Antithyroid Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Antithyroid Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Antithyroid Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Antithyroid Drug Revenue Market Share by Region (2021-2026) Table 17. Global Antithyroid Drug Revenue Market Share by Region (2027-2032) Table 18. Global Antithyroid Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Antithyroid Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Antithyroid Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Antithyroid Drug Sales Market Share by Region (2021-2026) Table 22. Global Antithyroid Drug Sales Market Share by Region (2027-2032) Table 23. Global Antithyroid Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antithyroid Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Antithyroid Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Antithyroid Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Antithyroid Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Antithyroid Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Antithyroid Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Antithyroid Drug Manufacturers, Product Type & Application Table 31. Global Antithyroid Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Antithyroid Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Antithyroid Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Antithyroid Drug Revenue Market Share by Type (2021-2026) Table 38. Global Antithyroid Drug Revenue Market Share by Type (2027-2032) Table 39. Global Antithyroid Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Antithyroid Drug Sales Market Share by Type (2021-2026) Table 43. Global Antithyroid Drug Sales Market Share by Type (2027-2032) Table 44. Global Antithyroid Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Antithyroid Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Antithyroid Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Antithyroid Drug Revenue Market Share by Application (2021-2026) Table 50. Global Antithyroid Drug Revenue Market Share by Application (2027-2032) Table 51. Global Antithyroid Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Antithyroid Drug Sales Market Share by Application (2021-2026) Table 55. Global Antithyroid Drug Sales Market Share by Application (2027-2032) Table 56. Global Antithyroid Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antithyroid Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Avet Pharmaceuticals Inc. Company Information Table 59. Avet Pharmaceuticals Inc. Business Overview Table 60. Avet Pharmaceuticals Inc. Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio Table 62. Avet Pharmaceuticals Inc. Recent Development Table 63. Par Pharmaceutical Company Information Table 64. Par Pharmaceutical Business Overview Table 65. Par Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Par Pharmaceutical Antithyroid Drug Product Portfolio Table 67. Par Pharmaceutical Recent Development Table 68. Zhaohui Pharmaceutical Company Information Table 69. Zhaohui Pharmaceutical Business Overview Table 70. Zhaohui Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio Table 72. Zhaohui Pharmaceutical Recent Development Table 73. Hemony Pharmaceutical Company Information Table 74. Hemony Pharmaceutical Business Overview Table 75. Hemony Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hemony Pharmaceutical Antithyroid Drug Product Portfolio Table 77. Hemony Pharmaceutical Recent Development Table 78. Pfizer Inc Company Information Table 79. Pfizer Inc Business Overview Table 80. Pfizer Inc Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Inc Antithyroid Drug Product Portfolio Table 82. Pfizer Inc Recent Development Table 83. Merck KGaA Company Information Table 84. Merck KGaA Business Overview Table 85. Merck KGaA Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck KGaA Antithyroid Drug Product Portfolio Table 87. Merck KGaA Recent Development Table 88. Teva Pharmaceuticals Company Information Table 89. Teva Pharmaceuticals Business Overview Table 90. Teva Pharmaceuticals Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Teva Pharmaceuticals Antithyroid Drug Product Portfolio Table 92. Teva Pharmaceuticals Recent Development Table 93. YanJing Pharm Company Information Table 94. YanJing Pharm Business Overview Table 95. YanJing Pharm Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. YanJing Pharm Antithyroid Drug Product Portfolio Table 97. YanJing Pharm Recent Development Table 98. North America Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 101. North America Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 102. North America Antithyroid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Antithyroid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 107. North America Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 108. North America Antithyroid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Antithyroid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Antithyroid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Antithyroid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 115. North America Antithyroid Drug Sales by Country (2027-2032) & (K Units) Table 116. North America Antithyroid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Antithyroid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 119. Canada Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 120. Europe Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 123. Europe Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 124. Europe Antithyroid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Antithyroid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 129. Europe Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 130. Europe Antithyroid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Antithyroid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Antithyroid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Antithyroid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 137. Europe Antithyroid Drug Sales by Country (2027-2032) & (K Units) Table 138. Europe Antithyroid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Antithyroid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 141. France Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 142. U.K. Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 143. Italy Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 145. China Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 146. China Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 147. China Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 148. China Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 149. China Antithyroid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Antithyroid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 152. China Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 153. China Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 154. China Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 155. China Antithyroid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Antithyroid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 160. Asia Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 161. Asia Antithyroid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Antithyroid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 166. Asia Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 167. Asia Antithyroid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Antithyroid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Antithyroid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Antithyroid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 174. Asia Antithyroid Drug Sales by Country (2027-2032) & (K Units) Table 175. Asia Antithyroid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Antithyroid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 178. South Korea Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 179. India Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 180. Australia Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Antithyroid Drug Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Antithyroid Drug Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Antithyroid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Antithyroid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Antithyroid Drug Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Antithyroid Drug Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Antithyroid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Antithyroid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Antithyroid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Antithyroid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Antithyroid Drug Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Antithyroid Drug Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Antithyroid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Antithyroid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 204. Argentina Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 205. Chile Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 206. Colombia Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 207. Peru Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 209. Israel Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 210. UAE Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 211. Turkey Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 212. Iran Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 213. Egypt Antithyroid Drug Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Antithyroid Drug Distributors List Table 217. Antithyroid Drug Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Antithyroid Drug Image Figure 2. Global Antithyroid Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Methimazole Image Figure 5. Propylthiouracil Image Figure 6. Other Image Figure 7. Global Antithyroid Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Antithyroid Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Other Image Figure 12. Global Antithyroid Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antithyroid Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Antithyroid Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Antithyroid Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Antithyroid Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Antithyroid Drug Sales (2021-2032) & (K Units) Figure 18. Global Antithyroid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Antithyroid Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Antithyroid Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Antithyroid Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Antithyroid Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Antithyroid Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Antithyroid Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Antithyroid Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Antithyroid Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Antithyroid Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Antithyroid Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Antithyroid Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Antithyroid Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Antithyroid Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Antithyroid Drug Sales Market Share by Type (2021-2032) Figure 34. Global Antithyroid Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Antithyroid Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Antithyroid Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Antithyroid Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Antithyroid Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Antithyroid Drug Sales Market Share by Application (2021-2032) Figure 40. North America Antithyroid Drug Revenue Share by Type (2021-2032) Figure 41. North America Antithyroid Drug Sales Share by Type (2021-2032) Figure 42. North America Antithyroid Drug Revenue Share by Application (2021-2032) Figure 43. North America Antithyroid Drug Sales Share by Application (2021-2032) Figure 44. North America Antithyroid Drug Revenue Share by Country (2021-2032) Figure 45. North America Antithyroid Drug Sales Share by Country (2021-2032) Figure 46. Europe Antithyroid Drug Revenue Share by Type (2021-2032) Figure 47. Europe Antithyroid Drug Sales Share by Type (2021-2032) Figure 48. Europe Antithyroid Drug Revenue Share by Application (2021-2032) Figure 49. Europe Antithyroid Drug Sales Share by Application (2021-2032) Figure 50. Europe Antithyroid Drug Revenue Share by Country (2021-2032) Figure 51. Europe Antithyroid Drug Sales Share by Country (2021-2032) Figure 52. China Antithyroid Drug Revenue Share by Type (2021-2032) Figure 53. China Antithyroid Drug Sales Share by Type (2021-2032) Figure 54. China Antithyroid Drug Revenue Share by Application (2021-2032) Figure 55. China Antithyroid Drug Sales Share by Application (2021-2032) Figure 56. Asia Antithyroid Drug Revenue Share by Type (2021-2032) Figure 57. Asia Antithyroid Drug Sales Share by Type (2021-2032) Figure 58. Asia Antithyroid Drug Revenue Share by Application (2021-2032) Figure 59. Asia Antithyroid Drug Sales Share by Application (2021-2032) Figure 60. Asia Antithyroid Drug Revenue Share by Country (2021-2032) Figure 61. Asia Antithyroid Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Antithyroid Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Antithyroid Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Antithyroid Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Antithyroid Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Antithyroid Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Antithyroid Drug Sales Share by Country (2021-2032) Figure 68. Antithyroid Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Antithyroid Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Methimazole
  • Propylthiouracil
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Avet Pharmaceuticals Inc.
  • Par Pharmaceutical
  • Zhaohui Pharmaceutical
  • Hemony Pharmaceutical
  • Pfizer Inc
  • Merck KGaA
  • Teva Pharmaceuticals
  • YanJing Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antithyroid Drug Market by Type
  3. 1.2.1 Global Antithyroid Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Methimazole
  5. 1.2.3 Propylthiouracil
  6. 1.2.4 Other
  7. 1.3 Antithyroid Drug Market by Application
  8. 1.3.1 Global Antithyroid Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Antithyroid Drug Market Dynamics
  1. 2.1 Antithyroid Drug Industry Trends
  2. 2.2 Antithyroid Drug Industry Drivers
  3. 2.3 Antithyroid Drug Industry Opportunities and Challenges
  4. 2.4 Antithyroid Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antithyroid Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antithyroid Drug Revenue by Region
  3. 3.2.1 Global Antithyroid Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antithyroid Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Antithyroid Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Antithyroid Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antithyroid Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antithyroid Drug Sales by Region
  9. 3.4.1 Global Antithyroid Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antithyroid Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Antithyroid Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Antithyroid Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antithyroid Drug Revenue by Manufacturers
  2. 4.1.1 Global Antithyroid Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antithyroid Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antithyroid Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antithyroid Drug Sales by Manufacturers
  6. 4.2.1 Global Antithyroid Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antithyroid Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antithyroid Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antithyroid Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antithyroid Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antithyroid Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antithyroid Drug Manufacturers, Product Type & Application
  13. 4.7 Global Antithyroid Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antithyroid Drug Market CR5 and HHI
  16. 4.8.2 2025 Antithyroid Drug Tier 1, Tier 2, and Tier 3
5 Antithyroid Drug Market by Type
  1. 5.1 Global Antithyroid Drug Revenue by Type
  2. 5.1.1 Global Antithyroid Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antithyroid Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antithyroid Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antithyroid Drug Sales by Type
  6. 5.2.1 Global Antithyroid Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antithyroid Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antithyroid Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antithyroid Drug Price by Type
6 Antithyroid Drug Market by Application
  1. 6.1 Global Antithyroid Drug Revenue by Application
  2. 6.1.1 Global Antithyroid Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antithyroid Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antithyroid Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antithyroid Drug Sales by Application
  6. 6.2.1 Global Antithyroid Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antithyroid Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antithyroid Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antithyroid Drug Price by Application
7 Company Profiles
  1. 7.1 Avet Pharmaceuticals Inc.
  2. 7.1.1 Avet Pharmaceuticals Inc. Company Information
  3. 7.1.2 Avet Pharmaceuticals Inc. Business Overview
  4. 7.1.3 Avet Pharmaceuticals Inc. Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
  6. 7.1.5 Avet Pharmaceuticals Inc. Recent Developments
  7. 7.2 Par Pharmaceutical
  8. 7.2.1 Par Pharmaceutical Company Information
  9. 7.2.2 Par Pharmaceutical Business Overview
  10. 7.2.3 Par Pharmaceutical Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Par Pharmaceutical Antithyroid Drug Product Portfolio
  12. 7.2.5 Par Pharmaceutical Recent Developments
  13. 7.3 Zhaohui Pharmaceutical
  14. 7.3.1 Zhaohui Pharmaceutical Company Information
  15. 7.3.2 Zhaohui Pharmaceutical Business Overview
  16. 7.3.3 Zhaohui Pharmaceutical Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
  18. 7.3.5 Zhaohui Pharmaceutical Recent Developments
  19. 7.4 Hemony Pharmaceutical
  20. 7.4.1 Hemony Pharmaceutical Company Information
  21. 7.4.2 Hemony Pharmaceutical Business Overview
  22. 7.4.3 Hemony Pharmaceutical Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hemony Pharmaceutical Antithyroid Drug Product Portfolio
  24. 7.4.5 Hemony Pharmaceutical Recent Developments
  25. 7.5 Pfizer Inc
  26. 7.5.1 Pfizer Inc Company Information
  27. 7.5.2 Pfizer Inc Business Overview
  28. 7.5.3 Pfizer Inc Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Inc Antithyroid Drug Product Portfolio
  30. 7.5.5 Pfizer Inc Recent Developments
  31. 7.6 Merck KGaA
  32. 7.6.1 Merck KGaA Company Information
  33. 7.6.2 Merck KGaA Business Overview
  34. 7.6.3 Merck KGaA Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck KGaA Antithyroid Drug Product Portfolio
  36. 7.6.5 Merck KGaA Recent Developments
  37. 7.7 Teva Pharmaceuticals
  38. 7.7.1 Teva Pharmaceuticals Company Information
  39. 7.7.2 Teva Pharmaceuticals Business Overview
  40. 7.7.3 Teva Pharmaceuticals Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Pharmaceuticals Antithyroid Drug Product Portfolio
  42. 7.7.5 Teva Pharmaceuticals Recent Developments
  43. 7.8 YanJing Pharm
  44. 7.8.1 YanJing Pharm Company Information
  45. 7.8.2 YanJing Pharm Business Overview
  46. 7.8.3 YanJing Pharm Antithyroid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 YanJing Pharm Antithyroid Drug Product Portfolio
  48. 7.8.5 YanJing Pharm Recent Developments
8 North America
  1. 8.1 North America Antithyroid Drug Market Size by Type
  2. 8.1.1 North America Antithyroid Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Antithyroid Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Antithyroid Drug Price by Type (2021-2032)
  5. 8.2 North America Antithyroid Drug Market Size by Application
  6. 8.2.1 North America Antithyroid Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Antithyroid Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Antithyroid Drug Price by Application (2021-2032)
  9. 8.3 North America Antithyroid Drug Market Size by Country
  10. 8.3.1 North America Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antithyroid Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antithyroid Drug Market Size by Type
  2. 9.1.1 Europe Antithyroid Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antithyroid Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Antithyroid Drug Price by Type (2021-2032)
  5. 9.2 Europe Antithyroid Drug Market Size by Application
  6. 9.2.1 Europe Antithyroid Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antithyroid Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Antithyroid Drug Price by Application (2021-2032)
  9. 9.3 Europe Antithyroid Drug Market Size by Country
  10. 9.3.1 Europe Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antithyroid Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Antithyroid Drug Market Size by Type
  2. 10.1.1 China Antithyroid Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Antithyroid Drug Sales by Type (2021-2032)
  4. 10.1.3 China Antithyroid Drug Price by Type (2021-2032)
  5. 10.2 China Antithyroid Drug Market Size by Application
  6. 10.2.1 China Antithyroid Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Antithyroid Drug Sales by Application (2021-2032)
  8. 10.2.3 China Antithyroid Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antithyroid Drug Market Size by Type
  2. 11.1.1 Asia Antithyroid Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antithyroid Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Antithyroid Drug Price by Type (2021-2032)
  5. 11.2 Asia Antithyroid Drug Market Size by Application
  6. 11.2.1 Asia Antithyroid Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antithyroid Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Antithyroid Drug Price by Application (2021-2032)
  9. 11.3 Asia Antithyroid Drug Market Size by Country
  10. 11.3.1 Asia Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antithyroid Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antithyroid Drug Market Size by Type
  2. 12.1.1 SAMEA Antithyroid Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antithyroid Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antithyroid Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Antithyroid Drug Market Size by Application
  6. 12.2.1 SAMEA Antithyroid Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antithyroid Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antithyroid Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Antithyroid Drug Market Size by Country
  10. 12.3.1 SAMEA Antithyroid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antithyroid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antithyroid Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antithyroid Drug Value Chain Analysis
  2. 13.1.1 Antithyroid Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antithyroid Drug Production Mode & Process
  6. 13.2 Antithyroid Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antithyroid Drug Distributors
  9. 13.2.3 Antithyroid Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst